HK1254739A1 - 從年長細胞群中富集和擴增高潛能人間充質幹細胞 - Google Patents
從年長細胞群中富集和擴增高潛能人間充質幹細胞Info
- Publication number
- HK1254739A1 HK1254739A1 HK18113751.2A HK18113751A HK1254739A1 HK 1254739 A1 HK1254739 A1 HK 1254739A1 HK 18113751 A HK18113751 A HK 18113751A HK 1254739 A1 HK1254739 A1 HK 1254739A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- enrich
- elderly
- stem cells
- mesenchymal stem
- cell populations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562250664P | 2015-11-04 | 2015-11-04 | |
PCT/US2016/060624 WO2017079621A1 (en) | 2015-11-04 | 2016-11-04 | Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1254739A1 true HK1254739A1 (zh) | 2019-07-26 |
Family
ID=58662777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113751.2A HK1254739A1 (zh) | 2015-11-04 | 2018-10-26 | 從年長細胞群中富集和擴增高潛能人間充質幹細胞 |
Country Status (8)
Country | Link |
---|---|
US (1) | US11802272B2 (zh) |
EP (1) | EP3370740A4 (zh) |
JP (2) | JP6871637B2 (zh) |
CN (1) | CN108601799A (zh) |
AU (1) | AU2016349701B2 (zh) |
CA (1) | CA3004296A1 (zh) |
HK (1) | HK1254739A1 (zh) |
WO (1) | WO2017079621A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190153386A1 (en) * | 2017-11-17 | 2019-05-23 | James R. Musick | Stem cell line for treatment of various medical conditions |
CA3114426A1 (en) | 2018-10-03 | 2020-04-09 | Stembiosys, Inc. | Amniotic fluid cell-derived extracellular matrix and uses thereof |
CA3130860A1 (en) | 2019-02-21 | 2020-08-27 | Stembiosys, Inc. | Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ecm, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004069172A2 (en) * | 2003-01-30 | 2004-08-19 | The Government of the United States of America as represented by the Department of Veterans Affairs | Multilineage-inducible cells and uses thereof |
PL2535403T3 (pl) * | 2005-12-08 | 2019-10-31 | Univ Louisville Res Found Inc | Bardzo małe komórki macierzyste typu embrionalnego (VSEL) oraz sposoby ich izolowania i zastosowania |
US8084023B2 (en) | 2007-01-22 | 2011-12-27 | The Board Of Trustees Of The University Of Arkansas | Maintenance and propagation of mesenchymal stem cells |
CN102333861A (zh) * | 2008-09-30 | 2012-01-25 | 路易斯维尔大学研究基金会有限公司 | 用于分离非常小的胚胎样(vsel)干细胞的方法 |
EP2414511B1 (en) | 2009-03-31 | 2017-07-26 | The Board of Regents of The University of Texas System | Isolation of human umbilical cord blood-derived mesenchymal stem cells |
WO2012033763A2 (en) | 2010-09-07 | 2012-03-15 | The Board Of Regents Of The University Of Texas System | Tissue-specific differentiation matrices and uses thereof |
US20140154219A1 (en) * | 2011-04-01 | 2014-06-05 | University Of Louisville Research Foundation, Inc. | Methods and compositions for large-scale isolation of very small embryonic-like (vsel) stem cells |
WO2016070057A1 (en) | 2014-10-30 | 2016-05-06 | Stembiosys, Inc. | Methods for maintaining and expanding mesenchymal stem cells on extracellular matrix coated microcarriers |
-
2016
- 2016-11-04 WO PCT/US2016/060624 patent/WO2017079621A1/en active Application Filing
- 2016-11-04 AU AU2016349701A patent/AU2016349701B2/en active Active
- 2016-11-04 CA CA3004296A patent/CA3004296A1/en not_active Abandoned
- 2016-11-04 US US15/773,520 patent/US11802272B2/en active Active
- 2016-11-04 EP EP16863074.7A patent/EP3370740A4/en active Pending
- 2016-11-04 CN CN201680077403.3A patent/CN108601799A/zh active Pending
- 2016-11-04 JP JP2018523011A patent/JP6871637B2/ja active Active
-
2018
- 2018-10-26 HK HK18113751.2A patent/HK1254739A1/zh unknown
-
2021
- 2021-04-09 JP JP2021066352A patent/JP7153951B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2016349701A1 (en) | 2018-05-24 |
US11802272B2 (en) | 2023-10-31 |
WO2017079621A1 (en) | 2017-05-11 |
US20180320140A1 (en) | 2018-11-08 |
JP7153951B2 (ja) | 2022-10-17 |
CA3004296A1 (en) | 2017-05-11 |
JP2021105047A (ja) | 2021-07-26 |
CN108601799A (zh) | 2018-09-28 |
AU2016349701B2 (en) | 2023-10-19 |
EP3370740A1 (en) | 2018-09-12 |
JP2018537440A (ja) | 2018-12-20 |
EP3370740A4 (en) | 2019-05-22 |
JP6871637B2 (ja) | 2021-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272541A (en) | Purified mesenchymal stem cell exosomes and uses thereof | |
EP3534921A4 (en) | POPULATIONS OF MESENCHYMAL STEM CELLS, THEIR PRODUCTS AND THEIR USE | |
HK1254948A1 (zh) | 源自間充質幹細胞的外泌體及其應用 | |
IL267616A (en) | Immunologically engineered pluripotent cells | |
IL259586A (en) | Genetically modified stem cells and their uses | |
SG11201801549VA (en) | Pluripotent stem cell production system | |
IL250689B (en) | Rearrangement of multipurpose stem cells | |
SG11201609053YA (en) | Multiplexed single cell gene expression analysis using template switch and tagmentation | |
HK1246342A1 (zh) | 產生源自幹細胞的β細胞的方法及其用途 | |
IL255480B (en) | Preparations containing mesenchymal stem cells and their uses | |
IL263265A (en) | Use of mesenchymal stem cells and their parts | |
IL270492B (en) | Transdifferentiated cell populations and methods of use thereof | |
SG11201808567RA (en) | Human stem cell derived endothelial cells, endothelial- hepatocyte co-culture system and uses thereof | |
EP3299023A4 (en) | MESENCHYMAL SUBSTITUTE CELL CULTIVATED IN HYPOXIA AND USE THEREOF | |
IL254156A0 (en) | Methods for producing neural stem cells and their use | |
IL275037A (en) | CRISPR-CAS9-modified CD34+ human hematopoietic stem and progenitor cells and uses thereof | |
GB201701509D0 (en) | Pluripotenet stem cells | |
HK1258172A1 (zh) | 神經前體細胞群體及其用途 | |
EP3362069A4 (en) | INCREASING BETA CELL REPLICATION AND / OR SURVIVAL | |
HK1254739A1 (zh) | 從年長細胞群中富集和擴增高潛能人間充質幹細胞 | |
ZA202000574B (en) | Mesenchymal stem cells as vaccine adjuvants and methods for using the same | |
HK1215786A1 (zh) | 充氣墊氣室,及充氣墊 | |
EP3321356A4 (en) | Mesenchymal stem cell, clonogenic amplification method thereof, separation method thereof and uses thereof | |
EP3288570A4 (en) | Modified stem cells and uses thereof | |
EP3160385A4 (en) | STEM CELLS OF SUB-POPULATIONS DERIVED FROM GONADES |